Educational guide explaining Muse cell therapy costs in the US in 2026. Cover: what factors affect pricing (physician expertise, cell sourcing, screening protocols), typical investment range, why authentic Dezawa-protocol sourcing matters for safety, and what patients should ask about cost transparency. Name Dr. Charles Pereyra, MD as the physician source. Cite Dezawa's foundational characterization, Noda 2020 first-in-human safety data, and Yamada 2018 homing mechanism. Include 3-4 FAQ H3 questions ending in '?'. Use hedged language throughout — 'investigational,' 'early studies,' 'individual responses vary.' State that Muse cell therapy is not FDA approved. Include the full FDA disclaimer. ~700 words, educational not promotional.
Disclaimer: This content is for informational purposes only and does not constitute medical advice. Results vary by individual. Consultation with a qualified physician is required. Springs Rejuvenation does not claim to diagnose, treat, cure, or prevent any disease.